These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
221 related articles for article (PubMed ID: 11191092)
1. Suppression of spermatogenesis with desogestrel and testosterone pellets is not enhanced by addition of finasteride. Kinniburgh D; Anderson RA; Baird DT J Androl; 2001; 22(1):88-95. PubMed ID: 11191092 [TBL] [Abstract][Full Text] [Related]
2. Comparison between testosterone enanthate-induced azoospermia and oligozoospermia in a male contraceptive study. III. Higher 5 alpha-reductase activity in oligozoospermic men administered supraphysiological doses of testosterone. Anderson RA; Wallace AM; Wu FC J Clin Endocrinol Metab; 1996 Mar; 81(3):902-8. PubMed ID: 8772548 [TBL] [Abstract][Full Text] [Related]
3. Establishing the minimum effective dose and additive effects of depot progestin in suppression of human spermatogenesis by a testosterone depot. Handelsman DJ; Conway AJ; Howe CJ; Turner L; Mackey MA J Clin Endocrinol Metab; 1996 Nov; 81(11):4113-21. PubMed ID: 8923869 [TBL] [Abstract][Full Text] [Related]
4. Depot testosterone with etonogestrel implants result in induction of azoospermia in all men for long-term contraception. Brady BM; Walton M; Hollow N; Kicman AT; Baird DT; Anderson RA Hum Reprod; 2004 Nov; 19(11):2658-67. PubMed ID: 15333595 [TBL] [Abstract][Full Text] [Related]
5. Investigation of hormonal male contraception in African men: suppression of spermatogenesis by oral desogestrel with depot testosterone. Anderson RA; Van Der Spuy ZM; Dada OA; Tregoning SK; Zinn PM; Adeniji OA; Fakoya TA; Smith KB; Baird DT Hum Reprod; 2002 Nov; 17(11):2869-77. PubMed ID: 12407041 [TBL] [Abstract][Full Text] [Related]
6. 7alpha-methyl-19-nortestosterone (MENT) vs testosterone in combination with etonogestrel implants for spermatogenic suppression in healthy men. Walton MJ; Kumar N; Baird DT; Ludlow H; Anderson RA J Androl; 2007; 28(5):679-88. PubMed ID: 17460095 [TBL] [Abstract][Full Text] [Related]
7. Suppression of spermatogenesis by etonogestrel implants with depot testosterone: potential for long-acting male contraception. Anderson RA; Kinniburgh D; Baird DT J Clin Endocrinol Metab; 2002 Aug; 87(8):3640-9. PubMed ID: 12161488 [TBL] [Abstract][Full Text] [Related]
8. Intramuscular testosterone enanthate plus very low dosage oral levonorgestrel suppresses spermatogenesis without causing weight gain in normal young men: a randomized clinical trial. Anawalt BD; Amory JK; Herbst KL; Coviello AD; Page ST; Bremner WJ; Matsumoto AM J Androl; 2005; 26(3):405-13. PubMed ID: 15867009 [TBL] [Abstract][Full Text] [Related]
9. Oral progestogen combined with testosterone as a potential male contraceptive: additive effects between desogestrel and testosterone enanthate in suppression of spermatogenesis, pituitary-testicular axis, and lipid metabolism. Wu FC; Balasubramanian R; Mulders TM; Coelingh-Bennink HJ J Clin Endocrinol Metab; 1999 Jan; 84(1):112-22. PubMed ID: 9920070 [TBL] [Abstract][Full Text] [Related]
10. Levonorgestrel implants (Norplant II) for male contraception clinical trials: combination with transdermal and injectable testosterone. Gonzalo IT; Swerdloff RS; Nelson AL; Clevenger B; Garcia R; Berman N; Wang C J Clin Endocrinol Metab; 2002 Aug; 87(8):3562-72. PubMed ID: 12161475 [TBL] [Abstract][Full Text] [Related]
11. Testosterone-dependent restoration of spermatogenesis in adult rats is impaired by a 5alpha-reductase inhibitor. O'Donnell L; Pratis K; Stanton PG; Robertson DM; McLachlan RI J Androl; 1999; 20(1):109-17. PubMed ID: 10100481 [TBL] [Abstract][Full Text] [Related]
12. Oral desogestrel with testosterone pellets induces consistent suppression of spermatogenesis to azoospermia in both Caucasian and Chinese men. Kinniburgh D; Zhu H; Cheng L; Kicman AT; Baird DT; Anderson RA Hum Reprod; 2002 Jun; 17(6):1490-501. PubMed ID: 12042267 [TBL] [Abstract][Full Text] [Related]
13. Dose-finding study of oral desogestrel with testosterone pellets for suppression of the pituitary-testicular axis in normal men. Martin CW; Riley SC; Everington D; Groome NP; Riemersma RA; Baird DT; Anderson RA Hum Reprod; 2000 Jul; 15(7):1515-24. PubMed ID: 10875859 [TBL] [Abstract][Full Text] [Related]
14. A multicentre study investigating subcutaneous etonogestrel implants with injectable testosterone decanoate as a potential long-acting male contraceptive. Brady BM; Amory JK; Perheentupa A; Zitzmann M; Hay CJ; Apter D; Anderson RA; Bremner WJ; Pollanen P; Nieschlag E; Wu FC; Kersemaekers WM Hum Reprod; 2006 Jan; 21(1):285-94. PubMed ID: 16172147 [TBL] [Abstract][Full Text] [Related]
15. Oral testosterone in oil: pharmacokinetic effects of 5alpha reduction by finasteride or dutasteride and food intake in men. Amory JK; Page ST; Bremner WJ J Androl; 2006; 27(1):72-8. PubMed ID: 16400081 [TBL] [Abstract][Full Text] [Related]
16. Comparison between testosterone enanthate-induced azoospermia and oligozoospermia in a male contraceptive study. V. Localization of higher 5 alpha-reductase activity to the reproductive tract in oligozoospermic men administered supraphysiological doses of testosterone. Anderson RA; Kelly RW; Wu FC J Androl; 1997; 18(4):366-71. PubMed ID: 9283948 [TBL] [Abstract][Full Text] [Related]
17. Novel male hormonal contraceptive combinations: the hormonal and spermatogenic effects of testosterone and levonorgestrel combined with a 5alpha-reductase inhibitor or gonadotropin-releasing hormone antagonist. Matthiesson KL; Amory JK; Berger R; Ugoni A; McLachlan RI; Bremner WJ J Clin Endocrinol Metab; 2005 Jan; 90(1):91-7. PubMed ID: 15509637 [TBL] [Abstract][Full Text] [Related]
18. Suppression of spermatogenesis by testosterone enanthate in Thai men. Aribarg A; Sukcharoen N; Chanprasit Y; Ngeamvijawat J; Kriangsinyos R J Med Assoc Thai; 1996 Oct; 79(10):624-9. PubMed ID: 8996996 [TBL] [Abstract][Full Text] [Related]
19. [Effect of selective 5alpha-reductase inhibitor or/and testosterone undecanoate on the reproductive function of male rats]. Jia Y; Cue YG; Wang XD; Wang XH; Tong JS; Ma DZ; Cai RF; Di FS Zhonghua Nan Ke Xue; 2005 Jan; 11(1):38-41. PubMed ID: 15704680 [TBL] [Abstract][Full Text] [Related]
20. Combined administration of low-dose gossypol acetic acid with desogestrel/mini-dose ethinylestradiol/testosterone undecanoate as an oral contraceptive for men. Yang ZJ; Ye WS; Cui GH; Guo Y; Xue SP Contraception; 2004 Sep; 70(3):203-11. PubMed ID: 15325889 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]